[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 2005

0.1% Tacrolimus Ointment in the Treatment of Discoid Lupus Erythematosus

Arch Dermatol. 2005;141(9):1170-1171. doi:10.1001/archderm.141.9.1170

Discoid lupus erythematosus (DLE), which is an autoimmune inflammatory disorder of the skin, often leads to scarring and alopecia. Current treatment options include topical and systemic glucocorticoids, antimalarial agents, and thalidomide. These treatments are often limited by a lack of efficacy or by adverse effects.

We conducted an open-label pilot study using 0.1% tacrolimus (Protopic) ointment for the treatment of 5 subjects with biopsy-proved DLE. All subjects were receiving stable doses of systemic DLE-directed therapies for at least 4 weeks before study entry and had not applied topical steroids to the treatment area for 4 weeks.

First Page Preview View Large
First page PDF preview
First page PDF preview